Heather Leibensperger

Statistics

Publications

Citations

H-Index

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Wisconsin–Madison

Heather Leibensperger is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and neuropharmacology.

Publications per year

2008–2018

Publications

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Tony W. Ho, Michel D. Ferrari, David W. Dodick et al. · The Lancet · 2008 · 529 citations

Medicine, Pharmacology, Pharmacotherapy +11

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May et al. · Biological Psychiatry · 2014 · 292 citations

Medicine, Pharmacology, Pharmacotherapy +10

Randomized, controlled trial of telcagepant over four migraine attacks

Andrew P. Ho, Carl Dahlöf, Stephen D. Silberstein et al. · Cephalalgia · 2010 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies ☆

Tony W. Ho, M. Backonja, J. Ma et al. · Pain · 2008 · 58 citations

Medicine, Pharmacology, Pharmacotherapy +17

Randomized, controlled, proof‐of‐concept trial of MK‐7622 in Alzheimer's disease

Tiffini Voss, Jerry Li, Jeffrey L. Cummings et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 51 citations · Full text

Medicine, Neurology, Pharmacology +12

1–5 of 5